Description

2-Methyl-6-(Pyridin-3-Yl)Imidazo[2,1-B]Thiazole is a heterocyclic organic compound featuring a fused imidazothiazole core substituted with a pyridinyl group, serving as a crucial advanced pharmaceutical intermediate. This compound is valued for its role in the synthesis of novel bioactive molecules, particularly in medicinal chemistry research and development. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, especially in areas like kinase inhibition and targeted oncology treatments.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly for kinase inhibitors and targeted cancer therapies.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Organic Synthesis Reagent: Serves as a versatile scaffold for constructing complex heterocyclic systems in academic and industrial research.
• Biochemical Tool Compound: Potential use in developing probes for studying biological pathways and enzyme functions.
• Agrochemical Research: Investigated as a precursor for developing new active ingredients with potential pesticidal or herbicidal activity.

Basic Information

Item	Detail
Product Name	2-Methyl-6-(Pyridin-3-Yl)Imidazo[2,1-B]Thiazole
CAS No.	96911-77-2
Molecular Formula	C11H9N3S
Molecular Weight	215.27 g/mol
Synonyms	2-Methyl-6-(3-pyridinyl)imidazo[2,1-b][1,3]thiazole; 2-Methyl-6-(pyridin-3-yl)imidazo[2,1-b]thiazole; 6-(3-Pyridinyl)-2-methylimidazo[2,1-b]thiazole; Imidazo[2,1-b]thiazole, 2-methyl-6-(3-pyridinyl)-; 96911-77-2
EINECS	Contact for details

Quality Control

Our 2-Methyl-6-(Pyridin-3-Yl)Imidazo[2,1-B]Thiazole is produced under a strict quality management system to ensure batch-to-batch consistency and high purity suitable for research and development applications. All materials are accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support custom synthesis and can tailor specifications to meet specific project requirements, including compliance with relevant ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.